The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Needle Free Diabetes Management-Global Market Insights and Sales Trends 2025
Synopsis
The global Needle Free Diabetes Management market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Needle Free Diabetes Management in various end use industries. The expanding demands from the Hospitals, Clinics and Other, are propelling Needle Free Diabetes Management market. Insulin Jet Injector, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Insulin Pen segment is estimated at % CAGR for the next seven-year period.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Needle Free Diabetes Management, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Needle Free Diabetes Management market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Needle Free Diabetes Management market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Needle Free Diabetes Management sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Needle Free Diabetes Management covered in this report include Zogenix, 3M, Antares Pharma Inc., Glide Pharmaceutical Technologies, Injex Pharma AG, Pharmajet, Inc., Bioject Medical Technologies, Medtronic and Johnson & Johnson, etc.
The global Needle Free Diabetes Management market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Zogenix
3M
Antares Pharma Inc.
Glide Pharmaceutical Technologies
Injex Pharma AG
Pharmajet, Inc.
Bioject Medical Technologies
Medtronic
Johnson & Johnson
Pancreum LLC
Tandem Diabetes Care
JDRF
Akra Dermojet
Global Needle Free Diabetes Management market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Needle Free Diabetes Management market, Segment by Type:
Insulin Jet Injector
Insulin Pen
Insulin Inhaler
Insulin Patch & Pump
Global Needle Free Diabetes Management market, by Application
Hospitals
Clinics
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Needle Free Diabetes Management companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Needle Free Diabetes Management market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Needle Free Diabetes Management in various end use industries. The expanding demands from the Hospitals, Clinics and Other, are propelling Needle Free Diabetes Management market. Insulin Jet Injector, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Insulin Pen segment is estimated at % CAGR for the next seven-year period.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Needle Free Diabetes Management, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Needle Free Diabetes Management market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Needle Free Diabetes Management market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Needle Free Diabetes Management sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Needle Free Diabetes Management covered in this report include Zogenix, 3M, Antares Pharma Inc., Glide Pharmaceutical Technologies, Injex Pharma AG, Pharmajet, Inc., Bioject Medical Technologies, Medtronic and Johnson & Johnson, etc.
The global Needle Free Diabetes Management market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Zogenix
3M
Antares Pharma Inc.
Glide Pharmaceutical Technologies
Injex Pharma AG
Pharmajet, Inc.
Bioject Medical Technologies
Medtronic
Johnson & Johnson
Pancreum LLC
Tandem Diabetes Care
JDRF
Akra Dermojet
Global Needle Free Diabetes Management market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Needle Free Diabetes Management market, Segment by Type:
Insulin Jet Injector
Insulin Pen
Insulin Inhaler
Insulin Patch & Pump
Global Needle Free Diabetes Management market, by Application
Hospitals
Clinics
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Needle Free Diabetes Management companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Needle Free Diabetes Management
1.1 Needle Free Diabetes Management Market Overview
1.1.1 Needle Free Diabetes Management Product Scope
1.1.2 Needle Free Diabetes Management Market Status and Outlook
1.2 Global Needle Free Diabetes Management Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Needle Free Diabetes Management Market Size by Region (2018-2029)
1.4 Global Needle Free Diabetes Management Historic Market Size by Region (2018-2023)
1.5 Global Needle Free Diabetes Management Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Needle Free Diabetes Management Market Size (2018-2029)
1.6.1 North America Needle Free Diabetes Management Market Size (2018-2029)
1.6.2 Europe Needle Free Diabetes Management Market Size (2018-2029)
1.6.3 Asia-Pacific Needle Free Diabetes Management Market Size (2018-2029)
1.6.4 Latin America Needle Free Diabetes Management Market Size (2018-2029)
1.6.5 Middle East & Africa Needle Free Diabetes Management Market Size (2018-2029)
2 Needle Free Diabetes Management Market by Type
2.1 Introduction
2.1.1 Insulin Jet Injector
2.1.2 Insulin Pen
2.1.3 Insulin Inhaler
2.1.4 Insulin Patch & Pump
2.2 Global Needle Free Diabetes Management Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Needle Free Diabetes Management Historic Market Size by Type (2018-2023)
2.2.2 Global Needle Free Diabetes Management Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Needle Free Diabetes Management Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Needle Free Diabetes Management Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Needle Free Diabetes Management Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Needle Free Diabetes Management Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Needle Free Diabetes Management Revenue Breakdown by Type (2018-2029)
3 Needle Free Diabetes Management Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Other
3.2 Global Needle Free Diabetes Management Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Needle Free Diabetes Management Historic Market Size by Application (2018-2023)
3.2.2 Global Needle Free Diabetes Management Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Needle Free Diabetes Management Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Needle Free Diabetes Management Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Needle Free Diabetes Management Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Needle Free Diabetes Management Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Needle Free Diabetes Management Revenue Breakdown by Application (2018-2029)
4 Needle Free Diabetes Management Competition Analysis by Players
4.1 Global Needle Free Diabetes Management Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Needle Free Diabetes Management as of 2022)
4.3 Date of Key Players Enter into Needle Free Diabetes Management Market
4.4 Global Top Players Needle Free Diabetes Management Headquarters and Area Served
4.5 Key Players Needle Free Diabetes Management Product Solution and Service
4.6 Competitive Status
4.6.1 Needle Free Diabetes Management Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Zogenix
5.1.1 Zogenix Profile
5.1.2 Zogenix Main Business
5.1.3 Zogenix Needle Free Diabetes Management Products, Services and Solutions
5.1.4 Zogenix Needle Free Diabetes Management Revenue (US$ Million) & (2018-2023)
5.1.5 Zogenix Recent Developments
5.2 3M
5.2.1 3M Profile
5.2.2 3M Main Business
5.2.3 3M Needle Free Diabetes Management Products, Services and Solutions
5.2.4 3M Needle Free Diabetes Management Revenue (US$ Million) & (2018-2023)
5.2.5 3M Recent Developments
5.3 Antares Pharma Inc.
5.3.1 Antares Pharma Inc. Profile
5.3.2 Antares Pharma Inc. Main Business
5.3.3 Antares Pharma Inc. Needle Free Diabetes Management Products, Services and Solutions
5.3.4 Antares Pharma Inc. Needle Free Diabetes Management Revenue (US$ Million) & (2018-2023)
5.3.5 Glide Pharmaceutical Technologies Recent Developments
5.4 Glide Pharmaceutical Technologies
5.4.1 Glide Pharmaceutical Technologies Profile
5.4.2 Glide Pharmaceutical Technologies Main Business
5.4.3 Glide Pharmaceutical Technologies Needle Free Diabetes Management Products, Services and Solutions
5.4.4 Glide Pharmaceutical Technologies Needle Free Diabetes Management Revenue (US$ Million) & (2018-2023)
5.4.5 Glide Pharmaceutical Technologies Recent Developments
5.5 Injex Pharma AG
5.5.1 Injex Pharma AG Profile
5.5.2 Injex Pharma AG Main Business
5.5.3 Injex Pharma AG Needle Free Diabetes Management Products, Services and Solutions
5.5.4 Injex Pharma AG Needle Free Diabetes Management Revenue (US$ Million) & (2018-2023)
5.5.5 Injex Pharma AG Recent Developments
5.6 Pharmajet, Inc.
5.6.1 Pharmajet, Inc. Profile
5.6.2 Pharmajet, Inc. Main Business
5.6.3 Pharmajet, Inc. Needle Free Diabetes Management Products, Services and Solutions
5.6.4 Pharmajet, Inc. Needle Free Diabetes Management Revenue (US$ Million) & (2018-2023)
5.6.5 Pharmajet, Inc. Recent Developments
5.7 Bioject Medical Technologies
5.7.1 Bioject Medical Technologies Profile
5.7.2 Bioject Medical Technologies Main Business
5.7.3 Bioject Medical Technologies Needle Free Diabetes Management Products, Services and Solutions
5.7.4 Bioject Medical Technologies Needle Free Diabetes Management Revenue (US$ Million) & (2018-2023)
5.7.5 Bioject Medical Technologies Recent Developments
5.8 Medtronic
5.8.1 Medtronic Profile
5.8.2 Medtronic Main Business
5.8.3 Medtronic Needle Free Diabetes Management Products, Services and Solutions
5.8.4 Medtronic Needle Free Diabetes Management Revenue (US$ Million) & (2018-2023)
5.8.5 Medtronic Recent Developments
5.9 Johnson & Johnson
5.9.1 Johnson & Johnson Profile
5.9.2 Johnson & Johnson Main Business
5.9.3 Johnson & Johnson Needle Free Diabetes Management Products, Services and Solutions
5.9.4 Johnson & Johnson Needle Free Diabetes Management Revenue (US$ Million) & (2018-2023)
5.9.5 Johnson & Johnson Recent Developments
5.10 Pancreum LLC
5.10.1 Pancreum LLC Profile
5.10.2 Pancreum LLC Main Business
5.10.3 Pancreum LLC Needle Free Diabetes Management Products, Services and Solutions
5.10.4 Pancreum LLC Needle Free Diabetes Management Revenue (US$ Million) & (2018-2023)
5.10.5 Pancreum LLC Recent Developments
5.11 Tandem Diabetes Care
5.11.1 Tandem Diabetes Care Profile
5.11.2 Tandem Diabetes Care Main Business
5.11.3 Tandem Diabetes Care Needle Free Diabetes Management Products, Services and Solutions
5.11.4 Tandem Diabetes Care Needle Free Diabetes Management Revenue (US$ Million) & (2018-2023)
5.11.5 Tandem Diabetes Care Recent Developments
5.12 JDRF
5.12.1 JDRF Profile
5.12.2 JDRF Main Business
5.12.3 JDRF Needle Free Diabetes Management Products, Services and Solutions
5.12.4 JDRF Needle Free Diabetes Management Revenue (US$ Million) & (2018-2023)
5.12.5 JDRF Recent Developments
5.13 Akra Dermojet
5.13.1 Akra Dermojet Profile
5.13.2 Akra Dermojet Main Business
5.13.3 Akra Dermojet Needle Free Diabetes Management Products, Services and Solutions
5.13.4 Akra Dermojet Needle Free Diabetes Management Revenue (US$ Million) & (2018-2023)
5.13.5 Akra Dermojet Recent Developments
6 North America
6.1 North America Needle Free Diabetes Management Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Needle Free Diabetes Management Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Needle Free Diabetes Management Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Needle Free Diabetes Management Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Needle Free Diabetes Management Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Needle Free Diabetes Management Market Dynamics
11.1 Needle Free Diabetes Management Industry Trends
11.2 Needle Free Diabetes Management Market Drivers
11.3 Needle Free Diabetes Management Market Challenges
11.4 Needle Free Diabetes Management Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
